DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Patel Chem Specialities Ltd (PATELCHEM) share price today?

Patel Chem Specialities Ltd (PATELCHEM) is trading at ₹93.95 on the BSE, up 2.23% on the day. Source: DocStoX.

What is the PE ratio of Patel Chem Specialities Ltd?

Patel Chem Specialities Ltd has a price-to-earnings (PE) ratio of 15.9 in the Commodities sector.

What is the market capitalisation of Patel Chem Specialities Ltd?

Patel Chem Specialities Ltd has a market capitalisation of approximately ₹229 crore.

Patel Chem Specialities Ltd

PATELCHEM·BSE·Commodities

₹93.95▲ +2.05 (+2.23%)

Commodities · Chemicals & Petrochemicals

A steady, established business

Day₹90.05

₹95.00

52W₹56

₹12158%

Open

₹90.90

High

₹95.00

Low

₹90.05

Prev Close

₹91.90

Volume

20.8K

VWAP

₹93.45

Snapshot

Key fundamentals

Market Cap

₹229 Cr

P/E Ratio

15.90Fair

P/B Ratio

2.30

EPS

₹5.91

Book Value

₹40.01

ROE

18.60%Strong

ROCE

35.00%Efficient

Dividend Yield

0.00%

Debt / Equity

0.15Low

Face Value

₹10.00

52W High

₹120.89

52W Low

₹56.10

Sector

Commodities

Industry

Chemicals & Petrochemicals

Fairly Valued

Narrow moatHigh uncertainty

Fair value estimate

₹79

▼ 16.2%downside

Trading at ₹94 — 16% above our estimate

BearFair valueBull

₹67₹79₹91

/100

Business quality — Solid

Growth 50Profitability 58Efficiency 100Valuation 89

Plain English

Our view

A steady, established business
Low debt relative to equity

Strengths

Low debt relative to equity
Capital is working hard (ROCE 35%)
Promoters hold a controlling stake

How we got there

Fair value methods

Residual income

30% ROE fading to 13% over ~10 yrs, on ₹40 book

₹84

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹67

Analyst target

No analyst coverage

—

Blended fair value₹79

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Capital is working hard (ROCE 35%)
Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

15.9Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

18.6%Strong

Above 15% is considered healthy for Indian equities

ROCE

35.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.15Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹229 Cr

P/B

2.30

EPS

₹5.91

Div Yield

—

What changed

Recent changes

Foreign investors-1.8% stake last quarter
Domestic institutions-0.1% stake last quarter
Promoters+0.28% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 15.9×

Growth

Strong

+26% rev CAGR

Profitability

Excellent

18.6% ROE

Financial health

Rock solid

D/E 0.15

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹19.44L Cr

Trades10

VWAP₹93.45

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+25.8%

+26.7%

10Y

—

Profit

+60.5%

+65.5%

10Y

—

EPS

—

10Y

—

Profile

Pros

Company has delivered good profit growth of 56.9% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 27.8%

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.28 pts; foreign investors sold 1.78 pts; domestic institutions reduced 0.11 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

69%

Promoter

Promoters

68.6%+0.28

Public

16.4%+2.93

FII / FPI

6.4%-1.78

DII

1.7%-0.11

Others

6.9%

Total shareholders

1,089+165 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter68.64%

FII6.41%

DII1.70%

Public16.36%

Others6.89%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting of pharmaceutical excipients and specialty chemicals.[1]